TheraGenetics Appoints Dr. Heiner Dreismann as Chairman of the Board and Mr. Robert Forrester as Director
Dr. Dreismann most recently served as President and Chief Executive Officer of Roche Molecular Systems, Inc. (RMS), the division of Hoffmann-La Roche Ltd. Mr. Robert Forrester serves as Executive Vice President and Chief Financial Officer of CombinatoRx, Incorporated and was formerly Senior Vice President of Finance and Corporate Development at Coley Pharmaceutical Group. Dr. Dreismann received a Ph.D. in microbiology/molecular biology and an M.A. in Biology from Westfaelische Wilhelms University in Muenster, Germany.
Mr. Robert Forrester has served as Executive Vice President and Chief Financial Officer of CombinatoRx, Incorporated since February 2004. Mr. Forrester established and is responsible for managing CombinatoRx Singapore. Prior to CombinatoRx, Mr. Forrester served as Senior Vice President of Finance and Corporate Development at Coley Pharmaceutical Group. From 1994 to 2000, he was a Managing Director of the Proprietary Investment Group at MeesPierson, part of the Fortis Group. Prior to MeesPierson, Mr. Forrester worked for BZW, UBS and Clifford Chance. Mr. Forrester holds an LL.B. from Bristol University.
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.